MetaCap

iSpecimen (ISPC) vs NRC Health (NRC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

NRC Health is the larger company by market cap ($533.9 million vs $2.6 million), about 202.1 times the size. NRC Health pays a dividend yielding 2.54%, while iSpecimen does not currently pay one. NRC Health converts more of its revenue into profit, with a net margin of 8.4% versus -543.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ISPC-58.52%NRC+24.62%
+39%-12%-63%
Oct 7, 20261 yearNov 20, 2026
ISPC-59.62%NRC+23.76%
+35%-14%-64%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ISPC versus NRC key metrics
MetricISPCNRC
Share price$0.4563$25.16
Market cap$2.64M$533.93M
1-day change-13.58%+0.68%
YTD return—+34.04%
1-year return—+42.47%
5-year return—-38.98%
P/E ratio (TTM)—93.19
Forward P/E—23.74
EPS (TTM)$-52.98$0.27
Dividend yield0.00%2.54%
Annual dividend$0.00$0.64
Revenue (latest FY)$1.93M$137.39M
Revenue growth (YoY)-79.24%-3.96%
Net income (latest FY)$-10.49M$11.60M
Gross margin11.18%—
Operating margin-465.42%16.44%
Net margin-543.68%8.44%
52-week high$27.44$27.60
52-week low$0.432$11.74
Distance from 52-week high-98.34%-8.84%
Analyst consensus—none
Avg. price target upside—+7.31%
Average volume598.66K110.81K
Shares outstanding5.79M21.22M
Employees7357
SectorHealth CareHealth Care
IndustryBiotechnology: Commercial Physical & Biological ResarchBiotechnology: Commercial Physical & Biological Resarch

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • NRC Health is about 202.1 times larger than iSpecimen by market value ($533.93M vs $2.64M).
  • NRC Health offers a meaningfully higher dividend yield (2.54% vs 0.00%).
  • NRC Health is more profitable, keeping 8.4 cents of every revenue dollar as net income versus -543.7 cents for iSpecimen.
  • NRC Health grew revenue faster in its latest fiscal year (-3.96% vs -79.24%).

About iSpecimen

ISPC stock →

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Health Care · Biotechnology: Commercial Physical & Biological Resarch · 7 employees

About NRC Health

NRC stock →

NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.

Health Care · Biotechnology: Commercial Physical & Biological Resarch · 357 employees

ISPC vs NRC FAQ

Which is bigger, iSpecimen or NRC Health?

NRC Health (NRC) is larger, with a market capitalization of $533.93M compared with $2.64M for iSpecimen (ISPC).

Which pays a higher dividend, iSpecimen or NRC Health?

NRC Health pays a dividend yielding 2.54%, while iSpecimen does not currently pay a regular dividend.

Are iSpecimen and NRC Health in the same industry?

Yes. Both are classified in the Biotechnology: Commercial Physical & Biological Resarch industry within the Health Care sector.

More comparisons